Technical Description
The invention introduces a new pharmaceutical composition of sulfonamide derivatives aimed at treating Alzheimer’s disease. These derivatives have unique properties that may improve treatment efficacy and safety.
Problems Addressed
- Symptomatic Treatment Only
- Single-Target Mechanism
- High IC50 Values
- High Cost
Tech Features
- Sulphonamide Based Agent
- InhibitsNeurodegeneration
- Low IC50 Value
- Multifunctional Drug
- Cost Effective
Target Audience
- Pharmaceutical Industry
- Biomedical Sector
- Elder Care Centers
- Healthcare Sector
Tech ID: P35-1418 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
